The race to one of medicine’s elusive goals—a universal flu vaccine—is heating up. On Tuesday, the National Institutes of Health announced the phase I clinical trial of one such potential candidate, which will involve up to 100 adult volunteers. In early experiments, the vaccine appeared to protect animals exposed to…
